Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting.

Courtney MR, Moler EJ, Osborne JA, Whitney G, Conard SE.

Diabetes Metab Syndr Obes. 2015 Sep 18;8:447-53. doi: 10.2147/DMSO.S78810. eCollection 2015.

2.

Suppression of premature termination codons as a therapeutic approach.

Keeling KM, Wang D, Conard SE, Bedwell DM.

Crit Rev Biochem Mol Biol. 2012 Sep;47(5):444-63. doi: 10.3109/10409238.2012.694846. Epub 2012 Jun 7. Review.

3.

Identification of eRF1 residues that play critical and complementary roles in stop codon recognition.

Conard SE, Buckley J, Dang M, Bedwell GJ, Carter RL, Khass M, Bedwell DM.

RNA. 2012 Jun;18(6):1210-21. doi: 10.1261/rna.031997.111. Epub 2012 Apr 27.

4.

The Game of Health©: an innovative lifestyle change program implemented in a family practice.

Courtney MR, Conard SE, Dunn P, Scarborough K.

J Am Acad Nurse Pract. 2011 Jun;23(6):289-97. doi: 10.1111/j.1745-7599.2011.00604.x. Epub 2011 Apr 12.

PMID:
21649771
5.

Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease.

Bays HE, Conard SE, Leiter LA, Bird SR, Lowe RS, Tershakovec AM.

Int J Cardiol. 2011 Dec 1;153(2):141-7. doi: 10.1016/j.ijcard.2010.08.043. Epub 2010 Sep 15.

PMID:
20837371
6.

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.

Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators.

Diabetes Obes Metab. 2009 Jun;11(6):611-22. doi: 10.1111/j.1463-1326.2009.01056.x.

PMID:
19515181
7.

Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.

Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.

Am J Cardiol. 2008 Dec 1;102(11):1489-94. doi: 10.1016/j.amjcard.2008.09.075. Epub 2008 Oct 23.

PMID:
19026302
8.

Substance use among senior medical students. A survey of 23 medical schools.

Baldwin DC Jr, Hughes PH, Conard SE, Storr CL, Sheehan DV.

JAMA. 1991 Apr 24;265(16):2074-8.

PMID:
2013926
9.

Resident physician substance use in the United States.

Hughes PH, Conard SE, Baldwin DC Jr, Storr CL, Sheehan DV.

JAMA. 1991 Apr 24;265(16):2069-73.

PMID:
2013925
10.

Substance use and the resident physician: a national study.

Conard SE, Hughes P, Baldwin D, Achenbach K, Sheehan D.

Res Med Educ. 1988;27:256-61.

PMID:
3265295

Supplemental Content

Loading ...
Support Center